Literature DB >> 10420228

Carcinoma in jejunal pancreatic heterotopia.

H R Makhlouf1, J L Almeida, L H Sobin.   

Abstract

BACKGROUND: Although heterotopic pancreas in the gastrointestinal tract is not uncommon, jejunal pancreatic heterotopia is a rare finding, and malignant transformation in such a location is very unusual.
METHODS: We encountered a case of jejunal carcinoma in pancreatic heterotopia and because of its rarity, we reviewed the Armed Forces Institute of Pathology experience as well as the literature. The clinical, histopathologic, and immunohistochemical features were studied.
RESULTS: In 109 patients diagnosed as having pancreatic heterotopia in the gastrointestinal tract between 1970 and 1997 at the Armed Forces Institute of Pathology, 67 cases (62%) occurred in the stomach, 42 (38%) in the small intestine, and none in the large intestine. We found 2 patients with adenocarcinoma arising in pancreatic heterotopia. The 2 cases arose in the jejunum. One was of the ductal type, while the other was an acinar cell carcinoma with focal ductular differentiation. In both cases the nontumoral pancreatic tissue contained ducts, acini, and islets. Review of the literature yielded 26 reports of 28 cases of carcinoma arising in heterotopic pancreas; of these, 18 were well documented. Only 1 occurred in the jejunum, and none was of the acinar type.
CONCLUSIONS: Carcinoma in pancreatic heterotopia is rare, and acinar cell carcinoma in pancreatic heterotopia is extremely rare. Recognition of carcinoma in pancreatic heterotopia is important to prevent its misinterpretation as a metastatic tumor.

Entities:  

Mesh:

Year:  1999        PMID: 10420228     DOI: 10.5858/1999-123-0707-CIJPH

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  40 in total

1.  The cantankerous pancreas.

Authors:  R Thomas Temes; Noreen Griffin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

Review 2.  Gastric adenomyoma: definitely benign or defiantly premalignant?

Authors:  Daphne P Ly; Nicola J Barnard; Roderich E Schwarz
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Mucinous cyst exhibiting severe dysplasia in gastric heterotopic pancreas associated with gastrointestinal stromal tumour.

Authors:  Antony Kaufman; David Storey; Cheok Soon Lee; Rajmohan Murali
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

4.  Adenocarcinoma of aberrant pancreas in the jejunum: report of a case.

Authors:  Kenji Fujiwara; Chihiro Nakahara; Toru Yamasaki; Toshimitsu Iwashita
Journal:  J Gastrointest Cancer       Date:  2010-06

5.  Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy.

Authors:  Emmet J Jordan; Olca Basturk; Jinru Shia; David S Klimstra; William Alago; Michael I D'Angelica; Ghassan K Abou-Alfa; Eileen M O'Reilly; Maeve A Lowery
Journal:  J Gastrointest Oncol       Date:  2017-10

6.  Review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

7.  Adenomyomatous hyperplasia of the ampulla of Vater presenting as acute pancreatitis.

Authors:  Sabo Tanimu
Journal:  BMJ Case Rep       Date:  2014-03-06

8.  Colonic carcinoma with a pancreatic acinar cell differentiation. A case report.

Authors:  Anna Maria Chiaravalli; Giovanna Finzi; Valentina Bertolini; Stefano La Rosa; Carlo Capella
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

9.  CT features of asymptomatic heterotopic pancreas in jejunal mesentery.

Authors:  Serdar Aslan; Mehmet Selim Nural
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

10.  Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.

Authors:  Kimihide Kusafuka; Etsuro Bando; Koji Muramatsu; Hiroaki Ito; Yutaka Tanizawa; Taiichi Kawamura; Toru Mochizuki; Masanori Terashima; Takashi Nakajima
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.